Crossmark

Efficacy of new immunomodulatory drugs on major adverse cardiovascular events in patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials

Crossref DOI link: https://doi.org/10.1186/s12872-025-05250-1

Published Online: 2025-11-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

He, Donghang

Li, Yuhan

Jiang, Zefei

Cao, Xin

Luo, Rong
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82274414, 32171182)
License Information

Text and Data Mining valid from 2025-11-10

Version of Record valid from 2025-11-10
More Information

Article History

Received: 1 August 2025

Accepted: 3 October 2025

First Online: 10 November 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below